Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 23.75 BATS BZX Real-Time Price As of 1:05pm ET |  +0.79 / +3.44%Today’s Change | 14.21 Today|||52-Week Range 37.75 | +40.04% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -19.4M | -24.6M | -10.9M | -21.8M | |
| Depreciation | 51.0K | 61.0K | 410.0K | 582.0K | ||
| Total Other Cash Flow | 2.4M | 2.6M | 2.7M | 1.6M | ||
| Funds From Operations | -17.0M | -21.9M | -7.8M | -19.6M | ||
| Funds From/For Other Operating Expenses | 1.1M | -2.7M | -7.4M | 1.2M | ||
| Net Cash Flow - Operating Activities | -18.1M | -19.2M | -460.0K | -20.8M | ||
| Investing | Increase In Investments | -33.7M | -17.4M | 0.00 | -6.6M | |
| Decrease In Investments | -- | 22.3M | 10.6M | 30.2M | ||
| Capital Expenditures | -181.0K | -74.0K | -251.0K | -1.5M | ||
| Fixed Asset Disposal | 0.00 | 0.00 | 29.0K | 0.00 | ||
| Net Cash Flow Investing | -33.8M | 4.9M | 10.4M | 22.1M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 9.9M | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 66.5M | 6.0K | 7.0M | 332.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 66.5M | 6.0K | 7.0M | 10.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 14.5M | -14.4M | 16.9M | 11.6M | ||
